| Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade JJ Ishizuka, RT Manguso, CK Cheruiyot, K Bi, A Panda, A Iracheta-Vellve, ... Nature 565 (7737), 43-48, 2019 | 580 | 2019 |
| The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity CK Baumgartner, H Ebrahimi-Nik, A Iracheta-Vellve, KM Hamel, ... Nature 622 (7984), 850-862, 2023 | 75 | 2023 |
| Proteomic analysis of exosomes and its application in HIV‐1 infection C Cheruiyot, Z Pataki, B Ramratnam, M Li PROTEOMICS–Clinical Applications 12 (5), 1700142, 2018 | 15 | 2018 |
| SILAC based proteomic characterization of exosomes from HIV-1 infected cells C Cheruiyot, Z Pataki, R Williams, B Ramratnam, M Li JoVE (Journal of Visualized Experiments), e54799, 2017 | 11 | 2017 |
| Stem-loop binding protein is a multifaceted cellular regulator of HIV-1 replication M Li, LD Tucker, JM Asara, CK Cheruiyot, H Lu, ZJ Wu, MC Newstein, ... The Journal of Clinical Investigation 126 (8), 3117-3129, 2016 | 7 | 2016 |
| Stem-loop binding protein is a multifaceted cellular regulator of HIV-1 replication. LM Li Ming, LD Tucker, JM Asara, CK Cheruiyot, LHF Lu HuaFei, ZJ Wu, ... | | 2016 |
